NCT01871077View on ClinicalTrials.gov

Safety and Tolerability of the Ophthalmic Solution PRO-156 in Ophthalmologically Healthy Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy
Interventions
DRUG

PRO-156

Drug: PRO-156 ophthalmic solution One drop of PRO-156 ophthalmic solution administered to each eye, four times a day for 10 days.

All Listed Sponsors
lead

Laboratorios Sophia S.A de C.V.

INDUSTRY

NCT01871077 - Safety and Tolerability of the Ophthalmic Solution PRO-156 in Ophthalmologically Healthy Volunteers. | Biotech Hunter | Biotech Hunter